Ledger.Open graph →
SEC Form D · filed June 1, 2015

PLASMATECH BIOPHARMACEUTICALS INC

Offering
$22.7M
Sold
$13.7M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
DALLAS, TX
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (19)

Stephen B. Howell · Dallas, TXDirectorStephen B. Thompson · Dallas, TXExecJeffrey H. Davis · Dallas, TXDirectorMark J. Alvino · Dallas, TXDirectorTodd B. Wider · Dallas, TXDirectorWilliam S. Gray · Charlottesville, VADirectorJames M. Greene · Charlottesville, VADirectorMichael J. Shea · Salem, ORExecTim B. Miller · Dallas, TXExec · DirectorSteven H. Rouhandeh · Dallas, TXExecMark J. Ahn · Dallas, TXDirectorScott Lennon · GRAND CAYMAN, Cayman IslandsDirectorRichard Hoge · DARIEN, CTDirectorCarrie L. Branovan · Pahoa, HIExecRussell C. Smith · Pahoa, HIDirectorTim B. Miller · Dallas, TXExec · DirectorSteven H. Rouhandeh · Dallas, TXExecTodd B. Wider · Dallas, TXDirectorMark J. Ahn · Dallas, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗